New Urine and Blood Markers for Acute Kidney Injury in Liver Transplant Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2009-01-31

Study Completion Date

2013-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to find new blood and urine tests that detect acute kidney injury earlier than our current blood tests in patients receiving a liver transplant.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant Recipients

NCT01289717

Kidney Transplant Kidney Transplantation

COMPLETED

Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients

NCT06025240

Kidney Transplant Renal Transplant Failure Kidney Transplant Rejection +5 more

RECRUITING

Evaluation of Kidney Disease in Liver Transplant Recipients

NCT00585429

Kidney Disease Liver Transplantation

WITHDRAWN

A Study of Novel Biomarkers of Kidney Dysfunction at Liver Transplant

NCT03376009

Liver Transplantation Liver Transplant; Complications Kidney Dysfunction

COMPLETED

Prospective Study of Urinary Markers of Fibrosis in Kidney Transplants

NCT01982903

Kidney Failure

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients with end stage liver disease that receive a liver transplant will be studied to determine if novel serum and urine biomarkers (serum cystatin C, urine interleukin-18 \[IL-18\] and urine neutrophil gelatinase associated lipocalin \[NGAL\]) can predict the outcome measures listed above.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Renal Insufficiency, Acute

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Liver transplant recipients

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* First time liver transplant recipient
* Cadaveric or living donor livers

Exclusion Criteria

* Unconscious patients or patients who cannot give consent
* Pregnant women
* Prisoners
* Patients receiving dialysis before or during liver transplant operation
* Patients receiving simultaneous liver-kidney transplants

Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No